How many employees does iECURE, inc. have?

iECURE, inc. has approximately 38 employees.

Where is iECURE, inc. headquartered?

iECURE is headquartered in Plymouth Meeting, Pennsylvania, with an office located at 620 W Germantown Pike #220.

What industry is iECURE, inc. in?

iECURE, inc. operates in Biotechnology.

When was iECURE, inc. founded?

iECURE, inc. was founded in 2020.

Is iECURE, inc. still active?

Yes, iECURE, inc. was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.

How do I sell to iECURE, inc.?

Research iECURE, inc.'s priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details.

Data Surfer

How it works Insights Pricing FAQ Contact Login

iECURE, inc.

Biotechnology

Plymouth Meeting, United States

38 employees

Founded 2020

iecure.com

Verified active February 2, 2026

Key Highlights

iECURE is a clinical-stage company focused on genome editing for liver disorders.
The company utilizes genetic medicine and in vivo gene insertion therapies.
iECURE aims to transform patient lives with devastating liver disorders.
Their core mission involves harnessing advancements in genetic medicine.
iECURE is dedicated to developing novel therapies for liver diseases.

About iECURE, inc.

iECURE is a clinical-stage genome editing company dedicated to transforming the lives of patients with devastating liver disorders by harnessing new advancements in genetic medicine and in vivo gene insertion therapies.

Company Facts

Ownership Private Company

Funding $115M

Technology Stack

in vivo gene editing
gene insertion

Why Contact iECURE, inc.?

iECURE is a clinical-stage genome editing company focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases.

Who Should Contact iECURE, inc. for Business?

Clinical-stage biotechnology company developing genetic medicines and gene insertion therapies.

More Biotechnology Companies

Antibody Therapeutics

4 employees

International Centre for Stem Cells Cancer and Biotechnology (ICSCCB)

4 employees

Freenome

394 employees

View all Biotechnology companies

Frequently Asked Questions

What does iECURE, inc. do?: iECURE is a clinical-stage genome editing company focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases.
How many employees does iECURE, inc. have?: iECURE, inc. has approximately 38 employees.
Where is iECURE, inc. headquartered?: iECURE is headquartered in Plymouth Meeting, Pennsylvania, with an office located at 620 W Germantown Pike #220.
What industry is iECURE, inc. in?: iECURE, inc. operates in Biotechnology.
When was iECURE, inc. founded?: iECURE, inc. was founded in 2020.
Is iECURE, inc. still active?: Yes, iECURE, inc. was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to iECURE, inc.?: Research iECURE, inc.'s priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.